Edition:
United States

Clinica Baviera SA (CBAV.MC)

CBAV.MC on Madrid SE C.A.T.S.

9.69EUR
21 Feb 2017
Change (% chg)

€-0.11 (-1.12%)
Prev Close
€9.80
Open
€9.65
Day's High
€9.99
Day's Low
€9.65
Volume
4,284
Avg. Vol
9,113
52-wk High
€10.38
52-wk Low
€4.70

CBAV.MC

Chart for CBAV.MC

About

Clinica Baviera SA is a Spain-based company engaged in the healthcare sector. The Company focuses on providing services within the field of ophthalmic medicine. The Company is specialized in the diagnosis and treatment of eye disorders, including myopia, hyperopia, astigmatism, cataracts, glaucoma, vitreous-retina and strabismus... (more)
No analyst recommendations are available for CBAV.MC.

Overall

Beta: 0.80
Market Cap(Mil.): €167.48
Shares Outstanding(Mil.): 16.31
Dividend: 0.17
Yield (%): 4.63

Financials

  CBAV.MC Industry Sector
P/E (TTM): 19.36 32.07 29.71
EPS (TTM): 0.53 -- --
ROI: -- 5.58 12.94
ROE: -- 8.87 14.09

BRIEF-Clinica Baviera plans to open new clinics after strong FY results

* FY net profit 7.9 million euros ($8.3 million) versus 4.8 million euros year ago

Feb 22 2017

BRIEF-Clinica Baviera to propose dividend of 0.31 euro gross per share

* Says to propose dividend payment of 0.31 euro ($0.3376) gross per share

Oct 25 2016

BRIEF-Clinica Baviera 9-month EBITDA of 12.2 mln euros, up 76 pct YoY

* 9-month net profit 6.1 million euros ($6.6 million) versus 2.3 million euros year ago

Oct 24 2016

BRIEF-Clinica Baviera to propose gross dividend of 0.48 euro per share

* Says its board approved to pay dividend of 0.17 euro ($0.1859) per share and to propose extraordinary dividend of 0.31 euro per share

Oct 20 2016

More From Around the Web

Earnings vs. Estimates